If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,127.00    0.50 (0.04%)
Bid:
1,125.50
Ask:
1,126.50
Spread: 1.00 (0.089%)
Market Cap: £9.52b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

9 Dec 2022 11:30

RNS Number : 2420J
Smith & Nephew Plc
09 December 2022
 

SMITH & NEPHEW PLC

 

9 December 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

On 8 December 2022, the following award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under an award agreement to Deepak Nath. 

 

VESTING OF A PERFORMANCE AWARD GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022

 

As set out in the announcement published on 3 May 2022, a Performance Award over 127,461 shares was granted to Deepak Nath with an expected vest date of 9 November 2022. The vest of this award was subject to the performance conditions applicable to the performance stock award over Siemens Healthineers AG ("SH") shares originally granted to Deepak Nath by SH on 9 November 2018.

 

In accordance with the terms of the award agreement, the expected vest date of 9 November 2022 was delayed so that the applicable performance criteria attaching to the Performance Award could be measured against the financial results of SH which were announced on 23 November 2022. It has been determined that, following completion of the performance measurement period, 91.985% of the award vests. 117,245 shares were therefore available for vest with the remaining balance of shares, 10,216, lapsing with immediate effect.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Final vest of a Performance Award granted on 29 April 2022 under the award agreement.

Date of Transaction

2022 - 12 - 08

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Deepak Nath

(Chief Executive Officer)

Director

10.96

117,245 (of which 28,650 were sold to cover taxes due and 88,595 retained)

N/A Single Transaction

97,784.00000 ordinary shares

0.01114%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLLFTLAIIF
Date   Source Headline
31st Oct 20184:00 pmRNSDirector/PDMR Shareholding
18th Oct 20183:54 pmRNSDividend Declaration
17th Oct 20187:00 amRNSNotice of Results
5th Oct 20184:36 pmRNSDirector/PDMR Shareholding
1st Oct 20181:29 pmRNSTotal Voting Rights
1st Oct 20187:00 amRNSNotice of Results
19th Sep 20188:48 amRNSDirector/PDMR Shareholding
3rd Sep 20181:23 pmRNSTotal Voting Rights
23rd Aug 20184:42 pmRNSDirector/PDMR Shareholding
16th Aug 20182:03 pmRNSDirector/PDMR Shareholding
16th Aug 20182:01 pmRNSDirector/PDMR Shareholding
9th Aug 201811:31 amRNSAdditional Listing
2nd Aug 20183:25 pmRNSTransaction in Own Shares
2nd Aug 20189:42 amRNSDirector/PDMR Shareholding
1st Aug 20183:07 pmRNSTransaction in Own Shares
1st Aug 201812:30 pmRNSBlock listing Interim Review
1st Aug 201811:47 amRNSTotal Voting Rights
31st Jul 20185:33 pmRNSTransaction in Own Shares
30th Jul 20189:16 amRNSTransaction in Own Shares
26th Jul 20187:00 amRNSHalf-year Report
11th Jul 20184:26 pmRNSDirector/PDMR Shareholding
4th Jul 20187:00 amRNSNotice of Results
2nd Jul 201812:24 pmRNSTotal Voting Rights
1st Jun 201812:24 pmRNSTotal Voting Rights
30th May 20182:26 pmRNSTransaction in Own Shares
23rd May 20185:47 pmRNSTransaction in Own Shares
22nd May 20185:38 pmRNSTransaction in Own Shares
18th May 20185:47 pmRNSTransaction in Own Shares
17th May 20185:58 pmRNSTransaction in Own Shares
16th May 20186:02 pmRNSTransaction in Own Shares
15th May 20183:01 pmRNSDirector/PDMR Shareholding
15th May 20189:39 amRNSTransaction in Own Shares
11th May 201810:06 amRNSDirector/PDMR Shareholding
10th May 20182:47 pmRNSDirector/PDMR Shareholding
10th May 20189:18 amRNSDirector/PDMR Shareholding
9th May 20185:25 pmRNSDirector/PDMR Shareholding
9th May 20181:50 pmRNSDirector/PDMR Shareholding
9th May 20188:09 amRNSDirector/PDMR Shareholding
8th May 201811:45 amRNSDirectorate Change
3rd May 20187:00 amRNSTrading Statement
1st May 201811:39 amRNSTotal Voting Rights
25th Apr 20188:47 amRNSDividend Declaration
18th Apr 20189:00 amRNSNotice of Results
18th Apr 20188:00 amRNSECC endorsed by Royal College of Surgeons
12th Apr 20184:12 pmRNSResult of AGM
9th Apr 20184:40 pmRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSDirectorate Change
3rd Apr 20181:15 pmRNSTotal Voting Rights
12th Mar 201812:18 pmRNSDirector/PDMR Shareholding
8th Mar 20181:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.